The article about Japan Cell Culture, Inc. was published in Nikkei Biothech.

https://bio.nikkeibp.co.jp/article/news/20151001/187680/

（Member registration is required in order to read the article.）

“Act on the Safety of Regenerative Medicine” enabled medical institutions to outsource the cell cultivation and processing to private companies.
Japan Cell Culture, Inc. provides services which are entrusted with cultivating and processing mesenchymal stem cells derived from autologous adipose tissues collected at medical institutions. Our CPC is designed on the basis of biosafety manual and permitted by Ministry of Health, Labour and Welfare. The clean rooms are controlled at Class 10000. Stem cells and materials are handled inside the Class 100 biological safety cabinets to prevent any contamination.
Please contact us if you are in need of cultivation of the mesenchymal stem cells.

Inquiry by Phone
TEL: +81-92-435-6222
(Mon.-Fri. 9:00 a.m.-5:15 p.m., JST)

（We are sorry that our service is available only in Japan now.）

Instruments used in CPC_01

Instruments used in CPC_02

In our cell processing center (CPC), thorough management is carried out in production of stem cell preparation by trained professional staff for the safety and high quality of processing cells.。

adipose-derived stem cells（ASCs）

Regenerative medicine is an attempt to cure diseases by raising the body’s natural healing power and it is an ideal treatment for the body when it has become possible. Also, expectations from various patients are getting bigger as new treatment. In 2012, the Nobel Prize in Medicine and Physiology awarded to the professor Shinya Yamanaka of Kyoto University for the discovery that mature cells can be reprogrammed to become pluripotent. In 2014, the world’s first regenerative therapy using iPS cells achieved by Dr. Masashi Takahashi is also attracting very strong attention.